2018
DOI: 10.1016/s0254-6272(18)30896-3
|View full text |Cite
|
Sign up to set email alerts
|

Post-marketing safety surveillance and reevaluation of Motherwort injection: A clinical study of 10 094 cases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 10 publications
0
3
0
Order By: Relevance
“…A postmarketing safety surveillance and reevaluation of motherwort injection in China conducting in 2015 showed that the incidence of adverse drug reactions (ADRs) was only 0.79‰ (8/10 094), the reported adverse events mainly included fever, chills, eyelid edema, pruritus, rash, nausea, and palpitation. All of these ADRs were mild in severity [30].…”
Section: Discussionmentioning
confidence: 99%
“…A postmarketing safety surveillance and reevaluation of motherwort injection in China conducting in 2015 showed that the incidence of adverse drug reactions (ADRs) was only 0.79‰ (8/10 094), the reported adverse events mainly included fever, chills, eyelid edema, pruritus, rash, nausea, and palpitation. All of these ADRs were mild in severity [30].…”
Section: Discussionmentioning
confidence: 99%
“…Given that the routine practice of using LJI is widespread in China, studies addressing the effects of LJI have been accumulating over the past few years. Most clinical trials and experience indicate that prophylactic use of LJI alone or in combination with carboprost tromethamine may have a good effect on the prevention of postpartum hemorrhage after delivery [3,8,9] . However, no well-designed and systematic evaluation of the efficacy and safety of LJI in combination with carboprost tromethamine has been found.…”
Section: Introductionmentioning
confidence: 99%
“…Most clinical trials and experience indicate that prophylactic use of LJI alone or in combination with carboprost tromethamine may have a good effect on the prevention of postpartum hemorrhage after delivery. [3,8,9] However, no welldesigned and systematic evaluation of the efficacy and safety of LJI in combination with carboprost tromethamine has been found. Therefore, we undertook a meta-analysis to assess the efficacy and safety of carboprost tromethamine combined with LJI for the prevention of postpartum hemorrhage in high-risk pregnant women to provide new evidence-based medical evidence for clinical treatment.…”
Section: Introductionmentioning
confidence: 99%